1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Brain Implants Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Brain Implants Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising cases of neurological disorders
- 5.1.2 Technological advancements in implant materials
5.2 Market Opportunities
- 5.2.1 Growth in neurological disorder treatments
- 5.2.2 Advancements in brain implant technology
5.3 Future Trends
- 5.3.1 Growth in brain implants for neurological conditions
- 5.3.2 Rise in brain-machine interface technology
5.4 Impact of Drivers and Restraints
6. North America Brain Implants Market Regional Analysis
6.1 North America Brain Implants Market Overview
6.2 North America Brain Implants Market Revenue 2020-2030 (US$ Million)
6.3 North America Brain Implants Market Forecast Analysis
7. North America Brain Implants Market Analysis – by Treatment
7.1 Deep Brain Stimulation
- 7.1.1 Overview
- 7.1.2 Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Spinal Cord Stimulation
- 7.2.1 Overview
- 7.2.2 Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vagus Nerve Stimulator
- 7.3.1 Overview
- 7.3.2 Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Invasive and Non-Invasive Brain-Computer Interface
- 7.4.1 Overview
- 7.4.2 Invasive and Non-Invasive Brain-Computer Interface: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Responsive Neurostimulation for Seizures
- 7.5.1 Overview
- 7.5.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Auditory Brainstem Implant
- 7.6.1 Overview
- 7.6.2 Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Ophthalmic Aid/Implant
- 7.7.1 Overview
- 7.7.2 Ophthalmic Aid/Implant: North America Brain Implants Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Brain Implants Market Analysis – by Application
8.1 Chronic Pain
- 8.1.1 Overview
- 8.1.2 Chronic Pain: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Parkinson\'s Disease
- 8.2.1 Overview
- 8.2.2 Parkinson\'s Disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Alzheimer\'s Disease
- 8.3.1 Overview
- 8.3.2 Alzheimer\'s Disease: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Epilepsy
- 8.4.1 Overview
- 8.4.2 Epilepsy: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Essential Tremor
- 8.5.1 Overview
- 8.5.2 Essential Tremor: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Depression
- 8.6.1 Overview
- 8.6.2 Depression: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Dystonia
- 8.7.1 Overview
- 8.7.2 Dystonia: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Amyotrophic Lateral Sclerosis
- 8.8.1 Overview
- 8.8.2 Amyotrophic Lateral Sclerosis: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Neurofibromatosis 2
- 8.9.1 Overview
- 8.9.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Brain Implants Market Analysis – by End User
9.1 Hospitals and Specialized Clinics/Neurological Centers
- 9.1.1 Overview
- 9.1.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Brain Implants Market – North America Analysis
10.1 North America
- 10.1.1 North America Brain Implants Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 North America Brain Implants Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 US: North America Brain Implants Market Breakdown, by Treatment
- 10.1.1.1.2 US: North America Brain Implants Market Breakdown, by Application
- 10.1.1.1.3 US: North America Brain Implants Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Canada: North America Brain Implants Market Breakdown, by Treatment
- 10.1.1.2.2 Canada: North America Brain Implants Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Brain Implants Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Mexico : North America Brain Implants Market Breakdown, by Treatment
- 10.1.1.3.2 Mexico : North America Brain Implants Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Brain Implants Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Brain Implants Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Blackrock Microsystems Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BrainGate
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Fisher Wallace Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Functional Neuromodulation Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medtronic Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Neuralink Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NeuroPace Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 NeuroSky Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Neurospine LLC
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 ONWARD Medical NV
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Paradromics Inc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Renishaw Plc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Synchron Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Brain Implants Market
